USF Health researchers are exploring psilocybin as a potential treatment for major depressive disorder (MDD), including treatment-resistant depression and postpartum depression. Drs. Ryan Wagoner and Debra Knudson Gonzalez discuss their groundbreaking clinical trials investigating psychedelic compounds for mental health treatment.